International Journal of Research in Pharmacy and Allied Science

ISSN: 2583-6544   |  Issues per year: Monthly  |   Indexed In: Google Scholar, CORE, ScienceOpen, Researchgate

ISSN:2583-6544

Abstract View

A Review on Antibiotics as Drug and Poison

Author(s): Ms. Vaishnavi D. Patil1, Ms. Sayali D. Patil2, Mr. Azam Z. Shaikh3, Dr. S. P. Pawar4

Email(s): 1azamph46@gmail.com

Address:

    Department of Pharmaceutics P.S.G.V.P.M’s College of Pharmacy, Shahada

Published In:   Volume - 2,      Issue - 2,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Antibiotics are powerful medicines that treat certain infections and, when used correctly, can save lives. They either prevent the growth of bacteria or destroy them. Normally, the immune system can kill bacteria before they can multiply and cause symptoms. White blood cells (WBC) attack harmful bacteria. Even when symptoms appear, the immune system is usually able to manage and fight off the infection. However, there are times when the number of harmful bacteria is too large for the immune system to eliminate them all. Antibiotics can help in this scenario. The first antibiotic was penicillin. Penicillin-based antibiotics such as ampicillin, amoxicillin, and penicillin G are still available and have been used for many years to treat a variety of infections. There are several types of modern antibiotics that are usually available only by prescription in the United States. Topical antibiotics are available in over-the-counter (OTC) creams and ointments. Modern medicine has changed as a result of antibiotics. They facilitate critical therapies and procedures and are crucial for the treatment of infectious disorders. Nevertheless, despite their popularity, their continued usage in the twenty-first century is threatened by two unrelated problems. The first is that over time, the bacteria that these medications are meant to kill develop a tolerance to them. The second is that traditional mechanisms of payment are no longer cost-effective for discovering and developing antibiotics. As a result, there are fewer businesses and research facilities focused on producing new antibiotics, creating a pipeline that is anemic and endangers our ability to control diseases.

Keywords:

Cite this article:
Ms. Vaishnavi D. Patil, Ms. Sayali D. Patil, Mr. Azam Z. Shaikh, Dr. S. P. Pawar. A Review on Antibiotics as Drug and Poison. IJRPAS, 2023; 2(2): 1-9.



1.        Antibiotics. NHS. 5 June 2014.

2.        Why antibiotics can't be used to treat your cold or flu 6 May 2017.

3.        "General Background: Antibiotic Agents". Alliance for the Prudent Use of Antibiotics. Archived from the original on 14 December 2014.

4.        The past, present, and future of antibiotics. Michel A. Cook Gerard D. Wright

5.         Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. (December 2013). "Antibiotic resistance-the need for global solutions". The Lancet. Infectious Diseases

6.        Considerations for determining if a natural product is an effective wound-healing agent. The International Journal of Lower Extremity Wounds Lindblad WJ (June 2008)..

7.        Forrest RD (March 1982). "Early history of wound treatment". Journal of the Royal Society of Medicine.

8.        Calderon CB, Sabundayo BP (2007). Antimicrobial Classifications: Drugs for Bugs. In Schwalbe R, Steele-Moore L, Goodwin AC. Antimicrobial Susceptibility Testing Protocols. CRC Press. Taylor & Frances group

9.        Calderon CB, Sabundayo BP (2007). Antimicrobial Classifications: Drugs for Bugs. In Schwalbe R, Steele-Moore L, Goodwin AC. Antimicrobial Susceptibility Testing Protocols. CRC Press. Taylor & Frances group

10.    Frith J. "Arsenic – the "Poison of Kings" and the "Saviour of Syphilis"". Journal of Military and Veterans' Health.

11.    Aminov RI (2010). "A brief history of the antibiotic era: lessons learned and challenges for the future". Frontiers in Microbiology.

12.    Irish contributions to the origins of antibiotics. Irish Journal of Medical Science.Kingston W (June 2008).

13.    Alexander Fleming (1881-1955): Discoverer of penicillin. Singapore Medical Journal.an SY, Tatsumura Y (July 2015).

15.    Sykes R (2001). "Penicillin: from discovery to product". Bulletin of the World Health Organization.

16.     Van Epps HL (February 2006). "René Dubos: unearthing antibiotics". The Journal of Experimental Medicine.

17.    Capocci M (1 January 2014). "Cold drugs. Circulation, production and intelligence of antibiotics in post-WWII years". Medicina Nei Secoli

18.    Kahn LH. Antimicrobial resistance: A one health perspective. Trans R Soc Trop Med Hyg. 2017;111:255–60.

20.    Penicillins Drugs.com Medically reviewed by C. Fookes, BPharm. Last updated on April 5, 2018.

21.    Cephalosporins Drugs.com Medically reviewed by C. Fookes, BPharm on July 20, 2018.

22.    Macrolides Healthgrades.Medically Reviewed By William C. Lloyd III, MD, FACS — Written By Sarah Lewis, PharmD Updated on April 27, 2021

23.    Quinolones drugs.com Written by C. Fookes, BPharm on April 12, 2018.

24.    Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions Aben Ovung, Jhimli Bhattacharyya. 2021 Mar 29.

25.     Tetracycline NIH Mollie C. Shutter; Hossein Akhondi. Last Update: July 4, 2022.

26.    Side effects, Antibiotics. NHS. 5 June 2014.

27.    National Estimates of Emergency Department Visits for Antibiotic Adverse Events Among Adults—United States, 2011–2015Andrew I. Geller, Maribeth C. Lovegrove, Nadine Shehab, PharmD, Lauri A. Hicks, Mathew R. P. Sapiano, and Daniel S. Budnitz.

28.    Clostridium difficile infection: a review of current and emerging therapies Andrew Ofosu 2016 Apr-Jun

29.    Bhullar K, Waglechner N, Pawlowski A, et al. Antibiotic resistance is prevalent in an isolated cave microbiome.

Related Images:



Recent Images



Neurological Complications among Pregnant and Post Partum Mothers in a Private Hospital, Yogyakarta, Indonesia
Review on Regulatory Affairs in Pharmaceutical Industry
Cucumber and Mint Soap: Preparation and Evaluation
Topical Delivery in Cosmetics: Enhancing Penetration and Bioavailability
Formulation and Evaluation of Polyherbal Soap
Gelatin: A Widely Used Pharmaceutical Excipient
Therapeutic insights into Saroglitazar: a dual PPAR- α/γ agonist targeting diabetic dyslipidaemia and NAFLD
A Comprehensive Review on Dyslipidemia and Obesity: Pathophysiology, Clinical Implications and Management Approaches
Antidiabetic Herbs and Polyherbal Antidiabetic Formulations –An Overview
Review on Clinical Research and Clinical Trials

Tags


Quick Links


Latest Issues

Popular Articles